IDiyas

For the Inventor, By the Inventor

Xi'an, China

Qianqian Zhao

USPTO Granted Patents = 25

Average Co-Inventor Count = 11.2

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Xi+3 an, CN (2022 - 2023)
  • Xi'an, CN (2019 - 2024)

Company Filing History:

goldMedal21 out of 104 
 
Shaanxi University of Science and Technology
 patents
silverMedal2 out of 9 
 
Xi'an Taikomed Pharmaceutical Technology Co., Ltd.
 patents
bronzeMedal2 out of 3 
 
Xi'an Kangyuansheng Biomedical Technology Co., Ltd.
 patents

Years Active: 2019-2024

Loading Chart...
25 patents (USPTO):
1. 11872202 - Pleuromutilin cinnamic acid ester compounds with activities against antibiotic-resistant infections (2024-01-16),
2. 11712457 - seed extract composition and its application in antibiotic-resistant infections (2023-08-01),
3. 11597714 - Pleuromulin lipoic acid ester with antibacterial activity and a method of preparing the same (2023-03-07),
4. 11518740 - Pleuromutilin (phenylthio)acetic acid ester with anti-drug resistant bacteria activity and a method of preparing the same (2022-12-06),
5. 11512049 - Pleuromutilin 2-[(diphenylmethyl)thio] acetic acid ester with anti-drug resistant bacteria activity and a method of preparing the same (2022-11-29),
6. 11510905 - Pleuromutilin (E)-4-(1-imidazoylmethyl)cinnamic acid ester with anti-drug resistant bacteria activity and a method of preparing the same (2022-11-29),
7. 11484598 - Pleuromulin rhein ester with anti-drug resistant bacteria activity and a method of preparing the same (2022-11-01),
8. 11401233 - Pleuromutilin salicylic acid ester with antibacterial activity and a method of preparing the same (2022-08-02),
9. 11376299 - Lilac ginkgo brick tea and method of preparing the same (2022-07-05),
10. 11306076 - Silibinin lipoic acid ester with hepatoprotective activity and a method of preparing the same (2022-04-19),
11. 11186607 - Pleuromutilin ursodeoxycholic acid ester with antibacterial activity and a method of preparing the same (2021-11-30),
12. 11117859 - Pleuromutilin hippuric acid ester with antibacterial activity and a method of preparing the same (2021-09-14),
13. 10995053 - Hydroxytyrosol ursolic acid ester with antioxidant activity and methods of preparing the same (2021-05-04),
14. 10941120 - 6-aminouracil cassic acid ester with antibacterial activity and a method of preparing the same (2021-03-09),
15. 10836703 - Hydroxytyrosol acitretin ester with antioxidant activity and a method of preparing the same (2020-11-17),

Title: **Qianqian Zhao: Innovator in Antibiotic-Resistant Infections**

Introduction

Qianqian Zhao is an esteemed inventor based in Xi'an, China, with a remarkable portfolio of 25 patents. His innovative contributions primarily focus on combating antibiotic-resistant infections, which is a critical area of healthcare research.

Latest Patents

Among his latest patents, Zhao has developed pleuromutilin cinnamic acid ester compounds that have significant activity against antibiotic-resistant infections. This compound is designed with a versatile formula, allowing various chemical groups to be integrated, which enhances its efficacy. Furthermore, Zhao has patented a seed extract composition aimed at treating antibiotic-resistant infections. This composition includes essential components such as echinacoside and oleuropein, and outlines a method for preparing the seed extract, demonstrating its potential in pharmaceutical applications.

Career Highlights

Qianqian Zhao has made substantial strides in his career, holding positions at reputable institutions like Shaanxi University of Science and Technology and Xi'an Taikomed Pharmaceutical Technology Co., Ltd. His work at these organizations has allowed him to drive research initiatives and develop groundbreaking solutions in antibiotic resistance.

Collaborations

Throughout his career, Zhao has collaborated with notable researchers, including Han Li and Chengyuan Liang. These partnerships have further enriched his innovative endeavors, leading to the significant advancements in treatment methodologies for antibiotic-resistant infections.

Conclusion

Qianqian Zhao continues to be a prominent figure in the field of pharmaceutical innovation, particularly in addressing the urgent issue of antibiotic resistance. His extensive patent portfolio and collaborative initiatives demonstrate his commitment to advancing medical science and improving health outcomes globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…